Brokerages Set National Health Investors, Inc. (NYSE:NHI) Target Price at $76.33

National Health Investors, Inc. (NYSE:NHI) has been assigned an average rating of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $76.33.

A number of equities analysts have weighed in on the company. Truist Financial boosted their price target on National Health Investors from $65.00 to $78.00 and gave the stock a “hold” rating in a research report on Friday, August 30th. Wells Fargo & Company lowered National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their target price for the stock from $81.00 to $86.00 in a report on Tuesday, October 1st. Bank of America initiated coverage on shares of National Health Investors in a research report on Tuesday, September 24th. They set a “buy” rating and a $92.00 price objective for the company. Finally, StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th.

National Health Investors Trading Up 0.4 %

Shares of National Health Investors stock opened at $71.75 on Friday. National Health Investors has a 12-month low of $51.59 and a 12-month high of $86.13. The company has a quick ratio of 10.29, a current ratio of 10.29 and a debt-to-equity ratio of 0.92. The business’s 50 day moving average is $76.63 and its 200-day moving average is $75.61. The stock has a market cap of $3.26 billion, a P/E ratio of 24.66, a P/E/G ratio of 4.87 and a beta of 1.04.

National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The firm had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business’s revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.08 EPS. Equities research analysts predict that National Health Investors will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 5.02%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio is currently 123.71%.

Institutional Trading of National Health Investors

Several hedge funds and other institutional investors have recently bought and sold shares of the business. Quarry LP bought a new position in shares of National Health Investors during the third quarter worth approximately $27,000. Strategic Financial Concepts LLC bought a new stake in shares of National Health Investors in the second quarter valued at approximately $28,000. Covestor Ltd grew its position in National Health Investors by 2,700.0% during the third quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 405 shares in the last quarter. Point72 DIFC Ltd bought a new position in National Health Investors during the 3rd quarter worth $35,000. Finally, International Assets Investment Management LLC acquired a new position in National Health Investors in the 2nd quarter valued at $36,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.